57 Active Studies

Cervical Cancer Clinical Trials Near You

Find 57 actively recruiting cervical cancer research studies near you. Connect with study sites, check eligibility, and explore new treatment options.

57Active Trials
93+Locations
37,216Participants Needed

Recruiting Studies

Advanced Search

Data: ClinicalTrials.gov · Source of record for eligibility and locations

Top Cities for Cervical Cancer Clinical Trials

Cervical Cancer clinical trials are recruiting across 93 cities. Here are the cities with the most active studies:

Cervical Cancer Trial Phases

NA(28 studies)
PHASE2(13 studies)
PHASE1(7 studies)
PHASE3(3 studies)
PHASE4(1 study)

43 research organizations are sponsoring cervical cancer trials.

About Cervical Cancer

Cervical cancer develops in the cervix and is primarily caused by persistent HPV infection. It is one of the most preventable cancers through HPV vaccination and screening. Treatment includes surgery, radiation, chemotherapy, and immunotherapy for advanced cases.

Clinical trials are advancing new treatments for cervical cancer. Currently, 57 studies are recruiting a combined 37,216 participants across the United States. Research is being conducted by 43 organizations including M.D. Anderson Cancer Center, Northwestern University, Atila Biosystems Inc. and 40 others.

2026 Cervical Cancer Research Landscape

As of July 2026, the cervical cancer clinical trial landscape includes 57 actively recruiting studies across 93 cities in the United States. These studies are collectively seeking 37,216 participants, with an average enrollment target of 653 per study.

The research spans multiple phases of development: 28 studies are in NA, 13 studies are in PHASE2, 7 studies are in PHASE1, 3 studies are in PHASE3, 1 study is in PHASE4. The presence of Phase 3 trials indicates that some cervical cancer treatments are in late-stage testing and may be approaching regulatory review.

Research is being led by 43 different organizations, including M.D. Anderson Cancer Center, Northwestern University, Atila Biosystems Inc., International Agency for Research on Cancer, Mayo Clinic, and 38 others. The large number of sponsors reflects significant research interest and investment in cervical cancer treatment advancement.

Geographically, cervical cancer trials are most concentrated in Houston, Texas (6 trials); Atlanta, Georgia (5 trials); La Jolla, California (5 trials); Birmingham, Alabama (5 trials); Little Rock, Arkansas (5 trials) and 7 other cities.

Featured Cervical Cancer Studies

Highlighted recruiting studies for cervical cancer, selected by enrollment size and research scope.

RecruitingNCT06843720 · NA

Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems

To learn about the attitudes toward implementing self-collection among healthcare providers and staff, participants, and other stakeholders; and to inform the development of patient education and provider training materials to aid in the implementation of self-collection in clinical settings.

Sponsor: M.D. Anderson Cancer Center· 7,100 participants· 1 location (Houston)
View full study details →
RecruitingNCT00005095

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

RATIONALE: To improve strategies for detection and prevention of early-stage disease. PURPOSE: This research study is collecting specimens and data to develop better methods for early detection and prevention of ovarian cancer among the high risk population and those who have the disease.

Sponsor: Northwestern University· 6,000 participants· 1 location (Chicago)
View full study details →
RecruitingNCT07232355

Prevention of Cervical Cancer Using the Genotyping Screening and Same-day Self-sampling

In May 2018, the World Health Organization (WHO) launched a strategy to eliminate cervical cancer. While this strategy seeks to achieve coverage of 70% in disease testing and 90% in treatment by 2030, it is estimated that these goals will not be achieved by most low- and middle- income (LMICs) countries until 2120 under existing conditions. Presently, more than 90% of worldwide cervical cancer cas...

Sponsor: Atila Biosystems Inc.· 5,000 participants· 1 location (Sunnyvale)
View full study details →

Frequently Asked Questions About Cervical Cancer Clinical Trials

Are there cervical cancer clinical trials near me?

Yes, there are 57 cervical cancer clinical trials currently recruiting across 93+ cities in the United States, including Houston, Texas; Atlanta, Georgia; La Jolla, California. Browse the studies above to find one at a location convenient for you.

How do I join a cervical cancer clinical trial?

To join a cervical cancer clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.

Are cervical cancer clinical trials free?

Yes, participation in cervical cancer clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.

What types of cervical cancer treatments are being studied?

Current cervical cancer clinical trials are testing a range of approaches across NA (28 studies), PHASE2 (13 studies), PHASE1 (7 studies), PHASE3 (3 studies), PHASE4 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 43 research organizations.

Is it safe to participate in cervical cancer clinical trials?

Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.

Data updated July 16, 2026 from ClinicalTrials.gov

About This Data

Data: ClinicalTrials.gov · Source of record for eligibility and locations

Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.

Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.

Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov